Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Neuro-Oncology
Do you take any additional precautions when treating skull base tumors in patients with Charcot-Marie-Tooth disease?
In particular, would you be concerned for a heightened risk of radiation-induced neuropathies?
Related Questions
Would you offer adjuvant radiotherapy for a gross totally resected WHO grade 2 hemangiopericytoma/MFT of the brain in a patient with active multiple sclerosis?
How would you treat grade 3 cauda equina meningioma status post biopsy only with a history of prior prostate/whole pelvis radiation?
How would you approach management of a patient who is status post resection of a WHO grade 1 planum sphenoidale meningioma which was adherent to the optic nerve?
How do you manage an intramedullary benign nerve sheath tumor post sub-total resection seen on post-operative MRI?
For a glioblastoma patient who had an MRI immediately postoperatively and you are able to repeat one closer to the time of CT simulation, do you use the more recent scan or the immediate postoperative scan for contouring (T2/FLAIR and T1 post)?
Would you offer post-operative radiation for a glomus tumor of the spine following decompressive laminectomy and incomplete resection?
How would you manage a radiation induced sarcoma of the spinal cord following R1 resection?
In an adult with localized spinal myxopapillary ependyoma managed with subtotal resection and 54 Gy radiation, how long should follow up MRI imaging continue, with what frequency, and for what volume?
Do you ever perform adaptive replanning for interfraction tumor volume changes appreciated during a fractionated SRS ( 5 fx) treatment for CNS metastases?
Do you use specific scalp dosimetry constraints to prevent chronic alopecia when treating partial brain volumes with VMAT?